Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Schenone

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Neurobiology of Disease|August 9, 2001
The D355V mutation decreases EGR2 binding to an element within the Cx32 promoterM Musso, P Balestra, E Bellone, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2010
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literatureL Benedetti, C Briani, D Franciotta, et al.
Neurology|January 14, 2004
Clinical and molecular findings in patients with giant axonal neuropathy (GAN)C Bruno, E Bertini, A Federico, et al.
Neurology|June 24, 2004
Thalidomide sensory neurotoxicity: a clinical and neurophysiologic studyG Cavaletti, A Beronio, L Reni, et al.
European Journal of Neurology|May 11, 2016
Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of lifeL Padua, C Pazzaglia, D Pareyson, et al.
Neuromuscular Disorders : NMD|November 4, 2015
GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical courseI Pezzini, A Geroldi, S Capponi, et al.
European Journal of Neurology|July 15, 2016
Nerve conduction velocity in CMT1A: what else can we tell?F Manganelli, C Pisciotta, M M Reilly, et al.
Nature Genetics|May 10, 2000
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2A Bolino, M Muglia, F L Conforti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2014
Is overwork weakness relevant in Charcot-Marie-Tooth disease?G Piscosquito, M M Reilly, A Schenone, et al.
European Journal of Neurology|August 1, 2015
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth diseaseG Piscosquito, M M Reilly, A Schenone, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Neurobiology of Disease|August 9, 2001
The D355V mutation decreases EGR2 binding to an element within the Cx32 promoterM Musso, P Balestra, E Bellone, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2010
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literatureL Benedetti, C Briani, D Franciotta, et al.
Neurology|January 14, 2004
Clinical and molecular findings in patients with giant axonal neuropathy (GAN)C Bruno, E Bertini, A Federico, et al.
Neurology|June 24, 2004
Thalidomide sensory neurotoxicity: a clinical and neurophysiologic studyG Cavaletti, A Beronio, L Reni, et al.
European Journal of Neurology|May 11, 2016
Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of lifeL Padua, C Pazzaglia, D Pareyson, et al.
Neuromuscular Disorders : NMD|November 4, 2015
GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical courseI Pezzini, A Geroldi, S Capponi, et al.
European Journal of Neurology|July 15, 2016
Nerve conduction velocity in CMT1A: what else can we tell?F Manganelli, C Pisciotta, M M Reilly, et al.
Nature Genetics|May 10, 2000
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2A Bolino, M Muglia, F L Conforti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2014
Is overwork weakness relevant in Charcot-Marie-Tooth disease?G Piscosquito, M M Reilly, A Schenone, et al.
European Journal of Neurology|August 1, 2015
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth diseaseG Piscosquito, M M Reilly, A Schenone, et al.
Pageof 10